In conclusion, it is conceivable that GOF mutant p53 isoforms contribute to enhance ROS levels in cancer cells through a coordinated regulation of redox-related enzymes and signaling pathways, including SESN1/AMPK/PGC-1α/UCP2 axis, favoring cancer cell growth without damaging mitochondria. This evidence concerns the gene TP53 and cancer.